Showcase Your Work

This is an informal session to help you connect with your LNP peers in a relaxed atmosphere to continue forging new and beneficial relationships. With an audience of leading large pharma and innovative biotech eager to hear the latest breakthroughs in extrahepatic targeted, you will have the opportunity to display a poster presenting your own research. Don’t miss out on the chance to connect, learn, and present.

 

  • Demonstrate your thought leadership in LNP screening, ionizable lipid design, and novel extrahepatic targeting strategies
  • Gain unparalleled visibility and exposure for your unique innovations in non-viral delivery and development for application in gene editing, cell therapy, mRNA medicines, and more
  • Engage in meaningful discussions and gain valuable feedback from industry peers working in formulations, drug delivery, discovery, and process development.
  • Attract the attention of industry stakeholders scouting for their next acquisition or co-development opportunity.
Viewing poster
poster session socialising
Explaining poster

How to Submit Your Poster

  • You must first register your place to attend the 5th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit
  • Submit an abstract for review to showcase your poster during the Scientific Poster Session
  • You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
  • Scientific Poster Session: Wednesday, June 3
  • Abstract Submission Deadline: Monday, May 18

T&Cs

  • Posters should not be used for sales and marketing purposes
  • If your company offers pay-for services, you will need to submit your poster request to our partnerships team -  sponsor@hansonwade.com
  • All abstracts are subject to approval by the conference organisers, who reserve the right to reject submissions

Explore the Full Event Guide

  • 23+ expert speakers from pioneering biotech and large pharma, including AbbVie, Strand Therapeutics, AstraZeneca, Mote Therapeutics, Corner Therapeutics, Novo Nordisk, Novartis, and more
  • Gain in-depth technical insights into achieving precise and selective delivery to muscle, adipose tissue, immune cells, and other extrahepatic targets
  • 6 interactive workshops, roundtables and panel discussions to solve challenges in targeted LNP analytics, scalability as well as compare innovative solutions in passive and active targeting
Brochure Preview - 5th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit 2026